221 related articles for article (PubMed ID: 41435)
21. Effects of 5-iodo-2'-deoxyuridine on ultrastructural localization of viral antigens in cultured cells infected with herpes simplex virus.
Yoshida H; Sakata H; Hiyama N; Iwamoto T
Jpn J Ophthalmol; 1983; 27(2):321-39. PubMed ID: 6312145
[TBL] [Abstract][Full Text] [Related]
22. Syntheses of virus-induced thymidine kinase and viral DNA in herpes simplex type 1 virus-infected chick embryo fibroblasts.
Roubal J; Závada V; Zelená D; Hirsch I
Acta Virol; 1977 May; 21(3):177-83. PubMed ID: 18914
[TBL] [Abstract][Full Text] [Related]
23. Isolation and characterization of herpes simplex virus resistant to nucleoside analogs.
Katz E; Rosenblat O; Pisanty S
Oral Surg Oral Med Oral Pathol; 1991 Sep; 72(3):296-9. PubMed ID: 1656355
[TBL] [Abstract][Full Text] [Related]
24. Comparative efficacy of three antiviral drugs in mice herpetic keratitis.
Inoue Y; Ohashi Y; Shimomura Y; Manabe R; Yamada M; Ueda S; Kato S
Jpn J Ophthalmol; 1989; 33(1):125-31. PubMed ID: 2543857
[TBL] [Abstract][Full Text] [Related]
25. [Comparison of therapeutic activity of idoxuridine and acyclovir in experimentally-induced herpetic keratitis in rabbits (author's transl)].
Colin C; Chastel C; Quillien MC; Renard G
J Fr Ophtalmol; 1981; 4(1):33-43. PubMed ID: 7217623
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the DNA polymerase and thymidine kinase genesof herpes simplex virus isolates from AIDS patients in whom acyclovirand foscarnet therapy sequentially failed.
Schmit I; Boivin G
J Infect Dis; 1999 Aug; 180(2):487-90. PubMed ID: 10395866
[TBL] [Abstract][Full Text] [Related]
27. Potent activity of 5-fluoro-2'-deoxyuridine and related compounds against thymidine kinase-deficient (TK-) herpes simplex virus: targeted at thymidylate synthase.
De Clercq E; Bères J; Bentrude WG
Mol Pharmacol; 1987 Aug; 32(1):286-92. PubMed ID: 3039343
[TBL] [Abstract][Full Text] [Related]
28. [Clinical resistance of herpetic keratitis to antiviral agents (author's transl)].
Colin J; Chastel C; Baikoff G; Renard G
J Fr Ophtalmol; 1981; 4(1):57-60. PubMed ID: 6260850
[TBL] [Abstract][Full Text] [Related]
29. Herpes simplex virus stromal keratitis is not titer-dependent and does not correlate with neurovirulence.
Grau DR; Visalli RJ; Brandt CR
Invest Ophthalmol Vis Sci; 1989 Dec; 30(12):2474-80. PubMed ID: 2556353
[TBL] [Abstract][Full Text] [Related]
30. In vitro and in vivo resistance of herpes simplex virus to 9-(2-hydroxyethoxymethyl)guanine (acycloguanosine).
Smith KO; Kennell WL; Poirier RH; Lynd FT
Antimicrob Agents Chemother; 1980 Feb; 17(2):144-50. PubMed ID: 6247967
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the development of resistant strains of Type 1 herpes simplex virus to in vitro antiviral activity of 5-iodo-2'-deoxyuridine or ribavirin.
Huffman JH; Allen LB; Sidwell RW
Ann N Y Acad Sci; 1977 Mar; 284(1):233-8. PubMed ID: 212974
[TBL] [Abstract][Full Text] [Related]
32. (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine in the therapy of thymidine kinase-positive and -deficient herpes simplex virus experimental keratitis.
Maudgal PC; De Clercq E
Invest Ophthalmol Vis Sci; 1991 May; 32(6):1816-20. PubMed ID: 1851733
[TBL] [Abstract][Full Text] [Related]
33. Recovery of a latent HSV-1 thymidine kinase negative strain following iontophoresis and co-cultivation in the ocularly-infected rabbit model.
Caudill JW; Romanowski E; Araullo-Cruz T; Gordon YJ
Curr Eye Res; 1986 Jan; 5(1):41-5. PubMed ID: 3007031
[TBL] [Abstract][Full Text] [Related]
34. HSV1 strain sensitivity in experimental rabbit keratitis: evolution under repeated topical IDU administrations.
Denis J; Langlois M; Elkaim M; Amiel C; Aymard M; Huraux JM
Curr Eye Res; 1987 Jan; 6(1):39-45. PubMed ID: 3030653
[TBL] [Abstract][Full Text] [Related]
35. (E)-5-(2-bromovinyl)-2'-Deoxyuridine in the treatment of experimental herpes simplex keratitis.
Maudgal PC; De Clercq E; Descamps J; Missotten L; De Somer P; Busson R; Vanderhaeghe H; Verhelst G; Walker RT; Jones AS
Antimicrob Agents Chemother; 1980 Jan; 17(1):8-12. PubMed ID: 7352751
[TBL] [Abstract][Full Text] [Related]
36. Thymidine kinase in IDU resistance.
Centifanto Y; Kaufman HE
Proc Soc Exp Biol Med; 1965 Oct; 120(1):23-6. PubMed ID: 4285237
[No Abstract] [Full Text] [Related]
37. Effect of trisodium phosphonoformate and idoxuridine on experimental herpes simplex keratitis in immunized and non-immunized rabbits.
Alenius S; Laurent U; Oberg B
Acta Ophthalmol (Copenh); 1980 Apr; 58(2):167-73. PubMed ID: 6249066
[TBL] [Abstract][Full Text] [Related]
38. Antiviral drug sensitivity in ocular herpes simplex virus infection.
Menage MJ; de Clercq E; van Lierde A; Easty VS; Darville JM; Cook SD; Easty DL
Br J Ophthalmol; 1990 Sep; 74(9):532-5. PubMed ID: 2168202
[TBL] [Abstract][Full Text] [Related]
39. Herpes simplex virus types 1 and 2: therapeutic response to antiviral drugs.
North RD; Pavan-Langston D; Geary P
Arch Ophthalmol; 1976 Jun; 94(6):1019-21. PubMed ID: 180942
[TBL] [Abstract][Full Text] [Related]
40. Light intensity on the photodynamic inactivation of herpes simplex keratitis.
Stanley JA; Pinnolis M
Am J Ophthalmol; 1976 Mar; 81(3):332-6. PubMed ID: 176890
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]